Join Growin Stock Community!

富禾生醫7773.TW Overview

TW StockBiotech. & Medical
(No presentation for 7773)
My Watchlist

Ticker

Value

empty

There is no following symbol in this watchlist.

富禾生醫（7773）Overall Performance

富禾生醫（7773）AI Analysis & Strategy

AI Strategy

Browsing restrictions can be lifted for a fee.

富禾生醫（7773） PowerScanner

Introduction >>

Power Squeeze

Surfing Trend

1 Day

1 Week

1 Month

富禾生醫（7773）Key Information

富禾生醫（7773）Profile

富禾生醫（7773）FAQ

This disclaimer is provided by TradingValley Inc. and includes any messages, news, research, analysis, prices or other information provided by the Company's website, the application "Growin App" and other services provided through the Company's website. It is only general market information for educational and investment decision-making reference, and does not constitute any investment advice. View Growin Disclaimer

No related data records

default symbol

7773

富禾生醫

29.40D

1.36%

(0.01)

  • When is 7773's latest earnings report released?

    The most recent financial report for 富禾生醫 (7773) covers the period of 2025Q2 and was published on 2025/06/30. This report is prepared according to IFRS/US GAAP standards and includes key financial indicators—Revenue, Profitability, Cash Flow, and Capital Structure. This information is essential for investors evaluating 7773's short-term business performance and financial health. For the latest updates on 7773's earnings releases, visit this page regularly.

  • How much cash does 7773 have?

    At the end of the period, 富禾生醫 (7773) held Total Cash and Cash Equivalents of 21.37M, accounting for 0.04 of total assets. Both current and quick ratios indicate robust short-term debt repayment ability. High cash reserves typically mean the company has strong liquidity, supporting operational needs, expansion investments, or shareholder returns.

  • Does 7773 go with three margins increasing?

    In the latest report, 富禾生醫 (7773) did not achieve the “three margins increasing” benchmark, with a gross margin of 74.18%%, operating margin of -141.76%%, and net margin of -117.1%%. This demonstrates limited improvement in profitability, which is a key signal for fundamental analysis. Investors should consider margin trends alongside other financial indicators to assess 7773's profit trajectory and future growth potential.